Literature DB >> 25756

Beta-blockers in migraine prophylaxis.

M Anthony.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 25756     DOI： 10.2165/00003495-197815040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  Propranolol for migraine prophylaxis.

Authors:  B Forssman; K G Henriksson; V Johannsson; L Lindvall; H Lundin
Journal:  Headache       Date:  1976-11       Impact factor: 5.887

2.  Prophylactic treatment of migraine with propranolol. A clinical trial.

Authors:  S E Borgesen; J L Nielsen; C E Moller
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

3.  Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis.

Authors:  O Sjaastad; P Stensrud
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

4.  Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis.

Authors:  K Ekbom; P O Lundberg
Journal:  Headache       Date:  1972-04       Impact factor: 5.887
  4 in total
  2 in total

1.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

2.  Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.

Authors:  J Mally; J H Connick; T W Stone
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.